Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Bioventures Investors

Investor type Private Equity Firm
Founders Marc Goldberg

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 37
Average round size
info
The average size of a deal this fund participated in
$15M
Portfolio companies 23
Rounds per year 1.54
Lead investments 5
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.38
Exits 8
Key employees 6
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Pharmaceutical
Summary

The main office of represented VC is situated in the Wellesley. The venture was found in North America in United States.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Bioventures Investors, startups are often financed by DSM Venturing, BASF Venture Capital, Techno Venture Management. The meaningful sponsors for the fund in investment in the same round are Lilly Ventures, Oxford Bioscience Partners, Advanced Technology Ventures. In the next rounds fund is usually obtained by Lilly Ventures, Polaris Partners, Oxford Bioscience Partners.

We can highlight the next thriving fund investment areas, such as Biotechnology, Manufacturing. Among the most popular portfolio startups of the fund, we may highlight Biolex Therapeutics, Ardais Corporation, Verax Biomedical. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low.

Speaking about the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this Bioventures Investors performs on 6 percentage points less the average number of lead investments. The top amount of exits for fund were in 2005. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2007. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 deals per year.

The fund was created by Marc Goldberg. Besides them, we counted 6 critical employees of this fund in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Bioventures Investors:
Typical Co-investors
Bioventures Investors is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Bioventures Investors:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
26 Venture -
Amuse Japan, Kanagawa Prefecture, Kawasaki
Avnatar Florida, Naples, United States
Baliopharm Germany, Nordrhein-Westfalen, North Rhine-Westphalia
Beijing Financial Street Capital Operation Center Beijing, Beijing, China
C31Ventures Central, Central Region, Singapore
Dai-Ichi Hoki Japan, Tokyo
Epic CG -
Guangzhou Nansha Financial Holding -
Matahari Department Stores (MDS) Banten, Indonesia, Jawa Barat
Millennium Technology Value Partners New York, New York, United States
Mountain Capital -
Moxxie Ventures California, San Francisco, United States
MXC Capital England, London, United Kingdom
Redmont Venture Partners Alabama, United States, Vestavia Hills
Shadow Ventures Atlanta, Georgia, United States
Sparebanken Vest New Jersey, North Bergen, United States
Swiss Immo Lab Switzerland, Zürich, Zurich
Vancoin Capital -
Zlvision Tech China, Qingdao Shi, Shandong

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Biotechnology
Health Care
Wellness
$23M08 Dec 2020 Richmond, Virginia, United States

Sonomotion

Clinical Trials
Innovation Management
Manufacturing
Medical Device
$10M12 Nov 2019 South San Francisco, California, United States

Kanova

Biopharma
Pharmaceutical
$17M26 Nov 2018 Jiangsu

Endotronix

Biotechnology
Health Care
Medical
Medical Device
Software
Wireless
$70M14 Sep 2018 Illinois, United States

Unified Information Devices

Bioinformatics
Consumer Research
iOS
Software
$2M10 Jul 2018 Illinois, United States

CoNextions Medical

Health Care
Medical Device
Wellness
$2M16 Mar 2017 Salt Lake City, Utah, United States

POC Medical Systems

Health Diagnostics
Medical
Medical Device
$21M10 Jan 2017 California, United States

Endotronix

Biotechnology
Health Care
Medical
Medical Device
Software
Wireless
$37M05 Jul 2016 Illinois, United States

Nano-Micro Technology

Hardware
Manufacturing
01 Jan 2015 Jiangsu

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Bioventures Investors?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: